Results 81 to 90 of about 7,093,593 (187)
Global regulatory frameworks and case studies of Advanced Therapy Medicinal Products (ATMPS)
Abstract Purpose Advanced Therapy Medicinal Products (ATMPs), which include tissue-engineered products, gene therapies, and somatic cell therapies, are at the pioneering of healthcare discovery and have the potential to cure ailments for which there were previously few or no therapy choices ...
Sravanthi Siliveri, Kavya Sri Ausali
openaire +1 more source
ATMP: The road to clinical application
479484ATMP („advanced therapy medicinal products“) sind eine neue Klasse von Arzneimitteln, die somatische Zelltherapeutika, Gentherapeutika und biotechnologisch bearbeitete Gewebeprodukte umfassen.
Fricke, Stephan +8 more
core +1 more source
Advanced Therapy Medicinal Products (ATMPs) represent a transformative class of innovative therapies based on genes, cells, or engineered tissues that aim to modify, repair, or replace biological functions at a fundamental level. This review provides a foundational overview of ATMPs, addressing their scientific basis, regulatory classification ...
Alfi Sophian +3 more
openaire +1 more source
The article presents considerations based on the regulations of EU and Polish law regarding the manufacture and use of advanced therapy medicinal products – hospital exemptions.
Pecyna, Marlena
core +1 more source
Advanced Therapy Medicinal Products
15211545In recent years advances in biology, biotechnology, and medical research have led to a new category of biologicals - the advanced therapy medicinal products (ATMPs).
Neuhaus, Vanessa +2 more
core +1 more source
Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial. [PDF]
McMullan C +24 more
europepmc +1 more source
Temporomandibular Joint Osteoarthritis: Regenerative Treatment by a Stem Cell Containing Advanced Therapy Medicinal Product (ATMP)-An In Vivo Animal Trial. [PDF]
Köhnke R +11 more
europepmc +1 more source
IntroductionAdvanced therapy medicinal product (ATMP) is a classification used by the European Medicines Agency (EMA) for cell-, gene-, and tissue-engineered therapies. Since the first ATMP received market authorization in 2009, a substantial proportion of these highly innovative therapies have been withdrawn from the European market.
Leong, Katherine, Macaulay, Richard
openaire +1 more source
Access to Advanced Therapy Medicinal Products in the EU: Where Do We Stand?
The European Union has a public health strategy and will generally ensure in all its policies and activities a “high level of human health protection”.
Mahalatchimy, A, A. Mahalatchimy
core +1 more source
Market Access for Advanced Therapy Medicinal Products (ATMPS) Begins at the Bench [PDF]
CA Jones, G Narayanan
openaire +1 more source

